Related Experiment Video
Updated: Apr 6, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
A Case for Inclusion of Genetic Counselors in Cardiac Care
Patricia Arscott1, Colleen Caleshu, Katrina Kotzer
1From the *Department of Internal Medicine, University of Michigan, Ann Arbor, MI; †Stanford Center for Inherited Cardiovascular Disease, Palo Alto, CA; ‡Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; §Department of Medicine-Cardiology, University of Minnesota Physicians, Minneapolis, MN; ¶Center for Individualized Medicine, Mayo Clinic, Rochester, MN; ‖University of Wisconsin School of Medicine and Public Health, Madison, WI; **Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH; ††Yale Cardiovascular Genetics Program, Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT; ‡‡Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN; §§North Memorial, Humphrey Cancer Center, Robbinsdale, MN; ¶¶Mayo Clinic, Rochester, MN; ‖‖Department of Genetics, Yale University School of Medicine, New Haven, CT; ***Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN; and †††Section of Genetics, Rush University Medical Center, Chicago, IL.
Abstract:
Recent advances in genetic testing for heritable cardiac diseases have led to an increasing involvement of the genetic counselor in cardiology practice. We present a series of cases collected from a nationwide query of genetics professionals regarding issues related to cost and utilization of genetic testing. Three themes emerged across cases: (1) choosing the most appropriate genetic test, (2) choosing the best person to test, and (3) interpreting results accurately. These cases demonstrate that involvement of a genetic counselor throughout the evaluation, diagnosis, and continuing management of individuals and families with inherited cardiovascular conditions helps to promote the efficient use of healthcare dollars.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Cardiomyopathy V: Interprofessional Care
Principles of Pharmacogenetics: Types of Genetic Variants

